Bence György, MD, PhD
Assistant Professor at the University of Basel and Head of Ophthalmic Translational Research Group at the Institute of Molecular and Clinical Ophthalmology Basel (IOB).

Research Approach

Gene therapy, genome editing, optogenetics, ophthalmology.


Leads the development of three preclinical translational research programs for vision loss at the IOB:
Cone-based optogenetics for vision restoration
Base editing for Stargardt disease
Prime editing for Usher Syndrome Type 2A
Received numerous awards for his work, including the RetinAward from the Swiss Vitreoretinal Group, the Excellence in Research Award from the American Society of Gene and Cell Therapy, and a Edward R. and Anne G. Lefler Center Fellowship
Recently elected to serve as a member of the Gene Therapy Working Group of the Swiss Expert Committee for Biosafety (SECB)


Dr. György is a translational scientist with a dual MD-PhD degree from the Semmelweis University, Budapest. He completed a postdoctoral fellowship at Harvard Medical School and The Massachusetts General Hospital with Drs. David Corey, Xandra Breakefield and Casey Maguire. He became head of the newly formed Translation Group at the IOB where his team is committed to bring therapies from bench to bedside. Dr. György is a leading expert in ophthalmic gene therapy and gene editing. His research focuses on developing new treatments for vision loss and other eye diseases. He has published numerous papers in high impact peer-reviewed journals, including Nature Medicine, Nature Communications and Neuron, and has given numerous presentations at international conferences.
Dr. György is passionate about translating his research findings into the clinic and helping patients with eye diseases. He is a dedicated translational scientist who is making a significant impact on the field of ophthalmology.